1. Home
  2. IQV
  3. IQV News

Latest IQVIA Holdings Inc. (IQV) News on August 30, 2025

IQV

MT Newswires

2 days ago

Veeva Systems' Guidance Boost Draws Mixed Investor Response Despite Q2 Beat, Oppenheimer Says

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies
IQV

PR Newswire

2 days ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

IQVIA Holdings Inc. (IQV): A Bull Case Theory
IQV

Insider Monkey

3 days ago

IQVIA Holdings Inc. (IQV): A Bull Case Theory

IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 64% Above Its Share Price
IQV

Simply Wall St.

4 days ago

IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 64% Above Its Share Price

What Are Wall Street Analysts' Target Price for IQVIA Holdings Stock?
IQV

Barchart

8 days ago

What Are Wall Street Analysts' Target Price for IQVIA Holdings Stock?

IQVIA Holdings (NYSE:IQV) investors are sitting on a loss of 24% if they invested a year ago
IQV

Simply Wall St.

8 days ago

IQVIA Holdings (NYSE:IQV) investors are sitting on a loss of 24% if they invested a year ago

IQVIA (IQV) Down 1.1% Since Last Earnings Report: Can It Rebound?
IQV

Zacks

9 days ago

IQVIA (IQV) Down 1.1% Since Last Earnings Report: Can It Rebound?

IQV

MT Newswires

11 days ago

Veeva Systems, IQVIA Dispute Resolution Removes Investor Concerns Around CRM Data Risk, Oppenheimer Says

Q2 Earnings Highs And Lows: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks
IQV

StockStory

11 days ago

Q2 Earnings Highs And Lows: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes
IQV

Business Wire

12 days ago

IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes

IQV

MT Newswires

2 months ago

Baird Adjusts Price Target on IQVIA Holdings to $159 From $161, Maintains Neutral Rating

Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV)
IQV

StockStory

2 months ago

Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV)

IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement’
IQV

Business Wire

2 months ago

IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement’

IQVIA Launches New AI Agents for Life Sciences and Healthcare
IQV

Business Wire

3 months ago

IQVIA Launches New AI Agents for Life Sciences and Healthcare

IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week
IQV

Simply Wall St.

3 months ago

IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week

Doximity Declines 4.4% in a Month: How to Play the Stock Now?
IQV

Zacks

3 months ago

Doximity Declines 4.4% in a Month: How to Play the Stock Now?

IQV

Argus Research

3 months ago

Analyst Report: IQVIA Holdings Inc

IQV

Argus Research

3 months ago

Market Digest: NUE, SRE, IQV

Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks
IQV

StockStory

3 months ago

Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks

IQV

MT Newswires

3 months ago

IQVIA Prices $2 Billion Senior Notes Due 2032

IQVIA Announces Pricing of Senior Notes
IQV

Business Wire

3 months ago

IQVIA Announces Pricing of Senior Notes

IQV

MT Newswires

3 months ago

Iqvia Plans $2 Billion Notes Offering

IQVIA Announces Offering of Senior Notes
IQV

Business Wire

3 months ago

IQVIA Announces Offering of Senior Notes

3 Value Stocks with Mounting Challenges
IQV

StockStory

3 months ago

3 Value Stocks with Mounting Challenges

IQV

GuruFocus.com

3 months ago

Ipca Laboratories Ltd (BOM:524494) Q4 2025 Earnings Call Highlights: Strong Domestic Growth and ...

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF
IQV

PR Newswire

3 months ago

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF

IQV

MT Newswires

3 months ago

Redburn Atlantic Adjusts Price Target on IQVIA Holdings to $188 From $255, Maintains Buy Rating

3 S&P 500 Stocks Facing Headwinds
IQV

StockStory

3 months ago

3 S&P 500 Stocks Facing Headwinds

IQV Q1 Earnings Call: Real-World Evidence Drives Outperformance Amid Sector Uncertainty
IQV

StockStory

3 months ago

IQV Q1 Earnings Call: Real-World Evidence Drives Outperformance Amid Sector Uncertainty

IQVIA and SCRI partner to enhance oncology trials
IQV

Clinical Trials Arena

3 months ago

IQVIA and SCRI partner to enhance oncology trials

IQVIA Holdings (NYSE:IQV) Partners With SCRI Innovations To Enhance Global Oncology Trials
IQV

Simply Wall St.

3 months ago

IQVIA Holdings (NYSE:IQV) Partners With SCRI Innovations To Enhance Global Oncology Trials

IQV

MT Newswires

3 months ago

IQVIA Teams Up With SCRI to Expedite Development of New Cancer Therapies

IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials
IQV

Business Wire

3 months ago

IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials

IQV

MT Newswires

4 months ago

Mizuho Adjusts Price Target on IQVIA Holdings to $190 From $210, Maintains Outperform Rating

3 Dawdling Stocks with Questionable Fundamentals
IQV

StockStory

4 months ago

3 Dawdling Stocks with Questionable Fundamentals

Investing in IQVIA (IQV)? Don't Miss Assessing Its International Revenue Trends
IQV

Zacks

4 months ago

Investing in IQVIA (IQV)? Don't Miss Assessing Its International Revenue Trends

IQV

MT Newswires

4 months ago

Morgan Stanley Adjusts Price Target on IQVIA Holdings to $185 From $250, Maintains Overweight Rating

IQV

Morningstar Research

4 months ago

Analyst Report: IQVIA Holdings Inc.

IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13
IQV

Business Wire

4 months ago

IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13

IQV

MT Newswires

4 months ago

Stephens Adjusts Price Target on IQVIA Holdings to $200 From $250, Maintains Overweight Rating

IQV

MT Newswires

4 months ago

Citigroup Adjusts Price Target on IQVIA Holdings to $160 From $210, Maintains Neutral Rating

IQV

MT Newswires

4 months ago

Deutsche Bank Adjusts Price Target on IQVIA Holdings to $200 From $260, Maintains Buy Rating

IQV

MT Newswires

4 months ago

Baird Adjusts Price Target on IQVIA Holdings to $161 From $195, Maintains Neutral Rating

IQV

MT Newswires

4 months ago

TD Cowen Adjusts Price Target on IQVIA Holdings to $168 From $175, Maintains Buy Rating

IQV

MT Newswires

4 months ago

Truist Securities Adjusts Price Target on IQVIA Holdings to $209 From $216, Maintains Buy Rating

IQV

MT Newswires

4 months ago

Jefferies Adjusts Price Target on IQVIA Holdings to $160 From $165, Maintains Hold Rating

IQV

MT Newswires

4 months ago

Leerink Partners Adjusts Price Target on IQVIA Holdings to $210 From $245, Maintains Outperform Rating

IQVIA (NYSE:IQV) Beats Q1 Sales Targets, Full-Year Sales Guidance is Optimistic
IQV

StockStory

4 months ago

IQVIA (NYSE:IQV) Beats Q1 Sales Targets, Full-Year Sales Guidance is Optimistic

IQVIA Holdings (IQV) Surpasses Q1 Earnings and Revenue Estimates
IQV

Zacks

4 months ago

IQVIA Holdings (IQV) Surpasses Q1 Earnings and Revenue Estimates

IQV

MT Newswires

4 months ago

IQVIA Holdings' Q1 Adjusted Earnings, Revenue Rise; Raises 2025 Revenue Guidance

IQV

Associated Press Finance

4 months ago

IQVIA: Q1 Earnings Snapshot

IQVIA Reports First-Quarter 2025 Results
IQV

Business Wire

4 months ago

IQVIA Reports First-Quarter 2025 Results

IQVIA (IQV) Q1 Earnings Report Preview: What To Look For
IQV

StockStory

4 months ago

IQVIA (IQV) Q1 Earnings Report Preview: What To Look For

After an up and down year, pharma’s R&D landscape is shifting again
IQV

Pharma Voice

4 months ago

After an up and down year, pharma’s R&D landscape is shifting again

IQVIA Gears Up to Report Q1 Earnings: What's in Store for the Stock?
IQV

Zacks

4 months ago

IQVIA Gears Up to Report Q1 Earnings: What's in Store for the Stock?

IQVIA (IQV) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
IQV

Zacks

4 months ago

IQVIA (IQV) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

RxSight, Inc. (RXST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
IQV

Zacks

4 months ago

RxSight, Inc. (RXST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?
IQV

Zacks

4 months ago

IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?

IQVIA Holdings Inc. (IQV): Among Billionaire Israel Englander’s Stock Picks with Huge Upside Potential
IQV

Insider Monkey

4 months ago

IQVIA Holdings Inc. (IQV): Among Billionaire Israel Englander’s Stock Picks with Huge Upside Potential

IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards
IQV

Business Wire

4 months ago

IQVIA celebrates Marie E. Lamont and Dr. Joanne Hackett, winners of Healthcare Businesswomen's Association Awards

IQV

Investing.com

4 months ago

HSBC shuffles MedTech stocks, cutting 4, upgrading 2

3 Healthcare Stocks That Concern Us
IQV

StockStory

4 months ago

3 Healthcare Stocks That Concern Us

IQV

MT Newswires

4 months ago

HSBC Downgrades IQVIA to Hold From Buy, Adjusts Price Target to $160 From $260

IQVIA named a front-runner in generative AI innovation by global industry research and analysis firm
IQV

Business Wire

4 months ago

IQVIA named a front-runner in generative AI innovation by global industry research and analysis firm

IQVIA to Announce First-Quarter 2025 Results on May 6, 2025
IQV

Business Wire

4 months ago

IQVIA to Announce First-Quarter 2025 Results on May 6, 2025

IQV

MT Newswires

4 months ago

Jefferies Adjusts Price Target on IQVIA Holdings to $165 From $205, Maintains Hold Rating

Stabilization and improvement seen in multiple key biopharma R&D metrics, says IQVIA Institute Report
IQV

Business Wire

4 months ago

Stabilization and improvement seen in multiple key biopharma R&D metrics, says IQVIA Institute Report

IQVIA (IQV) Moves 8.7% Higher: Will This Strength Last?
IQV

Zacks

5 months ago

IQVIA (IQV) Moves 8.7% Higher: Will This Strength Last?

IQV

MT Newswires

5 months ago

Truist Adjusts IQVIA Holdings' PT to $216 From $263, Keeps Buy Rating

IQV

MT Newswires

5 months ago

Barclays Downgrades IQVIA Holdings to Equalweight From Overweight, Adjusts PT to $170 From $235

IQV

MT Newswires

5 months ago

Evercore ISI Adjusts Price Target on IQVIA Holdings to $165 From $245, Maintains Outperform Rating

IQV

MT Newswires

5 months ago

Goldman Sachs Adjusts IQVIA Holdings Price Target to $200 From $230, Maintains Buy Rating

IQVIA Holdings Inc. (IQV): Among Stocks with Buy Ratings that Hedge Funds Love
IQV

Insider Monkey

5 months ago

IQVIA Holdings Inc. (IQV): Among Stocks with Buy Ratings that Hedge Funds Love

IQVIA Holdings (NYSE:IQV) Sees 13% Weekly Price Dip Amid Credit Agreement Amendment
IQV

Simply Wall St.

5 months ago

IQVIA Holdings (NYSE:IQV) Sees 13% Weekly Price Dip Amid Credit Agreement Amendment

IQV

MT Newswires

5 months ago

Leerink Partners Adjusts IQVIA Holdings Price Target to $245 From $259, Maintains Outperform Rating

Earnings grew faster than the respectable 6.4% CAGR delivered to IQVIA Holdings (NYSE:IQV) shareholders over the last five years
IQV

Simply Wall St.

5 months ago

Earnings grew faster than the respectable 6.4% CAGR delivered to IQVIA Holdings (NYSE:IQV) shareholders over the last five years

IQV

MT Newswires

5 months ago

Baird Adjusts IQVIA Holdings Price Target to $195 From $220, Maintains Neutral Rating

Is IQVIA Holdings (NYSE:IQV) A Risky Investment?
IQV

Simply Wall St.

5 months ago

Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

IQV

Morningstar Research

5 months ago

Analyst Report: IQVIA Holdings Inc.

Here's Why Investors Must Hold IQV Stock in Their Portfolios Now
IQV

Zacks

5 months ago

Here's Why Investors Must Hold IQV Stock in Their Portfolios Now

What Is IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Doing?
IQV

Simply Wall St.

5 months ago

What Is IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Doing?

Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks
IQV

StockStory

5 months ago

Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks
IQV

StockStory

5 months ago

Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks

Why IQVIA Holdings Inc. (IQV) is Among the Best Diagnostics Stocks to Invest in Right Now
IQV

Insider Monkey

5 months ago

Why IQVIA Holdings Inc. (IQV) is Among the Best Diagnostics Stocks to Invest in Right Now

Boasting A 23% Return On Equity, Is IQVIA Holdings Inc. (NYSE:IQV) A Top Quality Stock?
IQV

Simply Wall St.

5 months ago

Boasting A 23% Return On Equity, Is IQVIA Holdings Inc. (NYSE:IQV) A Top Quality Stock?

IQVIA Holdings (IQV) Fell on Lowered Guidance
IQV

Insider Monkey

5 months ago

IQVIA Holdings (IQV) Fell on Lowered Guidance

3 Reasons IQV is Risky and 1 Stock to Buy Instead
IQV

StockStory

5 months ago

3 Reasons IQV is Risky and 1 Stock to Buy Instead

IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 100% Above Its Share Price
IQV

Simply Wall St.

5 months ago

IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 100% Above Its Share Price

IQV

MT Newswires

6 months ago

Mizuho Adjusts Price Target on IQVIA Holdings to $242 From $247, Maintains Outperform Rating

IQVIA Holdings (NYSE:IQV) Secures Loan Refinancing To Reduce Interest Rate By 0.25% Points
IQV

Simply Wall St.

6 months ago

IQVIA Holdings (NYSE:IQV) Secures Loan Refinancing To Reduce Interest Rate By 0.25% Points

IQV

MT Newswires

6 months ago

Argus Adjusts IQVIA Holdings Price Target to $245 From $260, Maintains Buy Rating

IQV

Argus Research

6 months ago

Analyst Report: IQVIA Holdings Inc

IQV

Argus Research

6 months ago

Market Digest: AES, HST, MCD, PGR, WSM, IQV, HPE

IQVIA recognized as a leader in IDC MarketScape’s 2024 assessment for decentralized clinical trial technologies and consulting services
IQV

Business Wire

6 months ago

IQVIA recognized as a leader in IDC MarketScape’s 2024 assessment for decentralized clinical trial technologies and consulting services

IQVIA Gains From Diversified Client Base Despite Low Liquidity Woes
IQV

Zacks

6 months ago

IQVIA Gains From Diversified Client Base Despite Low Liquidity Woes

IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials
IQV

Business Wire

6 months ago

IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials

Earnings grew faster than the favorable 8.3% CAGR delivered to IQVIA Holdings (NYSE:IQV) shareholders over the last five years
IQV

Simply Wall St.

6 months ago

Earnings grew faster than the favorable 8.3% CAGR delivered to IQVIA Holdings (NYSE:IQV) shareholders over the last five years

IQV

MT Newswires

6 months ago

Citigroup Adjusts Price Target on IQVIA Holdings to $210 From $225, Maintains Neutral Rating

IQVIA Holdings (NYSE:IQV) Seems To Use Debt Quite Sensibly
IQV

Simply Wall St.

6 months ago

IQVIA Holdings (NYSE:IQV) Seems To Use Debt Quite Sensibly

IQVIA Holdings (IQV) is a Top-Ranked Value Stock: Should You Buy?
IQV

Zacks

6 months ago

IQVIA Holdings (IQV) is a Top-Ranked Value Stock: Should You Buy?

Share on Social Networks: